Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Bought by Fourth Sail Capital LP

Fourth Sail Capital LP lifted its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 61.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,171,102 shares of the company’s stock after acquiring an additional 1,209,277 shares during the quarter. Bioceres Crop Solutions accounts for approximately 6.3% of Fourth Sail Capital LP’s portfolio, making the stock its 5th largest holding. Fourth Sail Capital LP owned about 0.05% of Bioceres Crop Solutions worth $24,957,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Oppenheimer & Co. Inc. purchased a new position in shares of Bioceres Crop Solutions during the 1st quarter worth approximately $139,000. Lazard Asset Management LLC acquired a new position in shares of Bioceres Crop Solutions during the 1st quarter worth $212,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Bioceres Crop Solutions in the 2nd quarter valued at about $472,000. Oak Family Advisors LLC lifted its stake in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after purchasing an additional 1,208 shares during the period. Finally, Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $448,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

BIOX has been the topic of several research analyst reports. Canaccord Genuity Group decreased their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Roth Mkm lowered their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Oppenheimer cut their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st. Finally, Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Bioceres Crop Solutions has a consensus rating of “Buy” and a consensus target price of $12.13.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock opened at $6.17 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.86 and a current ratio of 1.27. Bioceres Crop Solutions Corp. has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The stock has a fifty day moving average of $7.50 and a two-hundred day moving average of $9.73. The company has a market capitalization of $387.77 million, a price-to-earnings ratio of 308.50 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The firm had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same period in the previous year, the firm posted ($0.07) EPS. On average, analysts anticipate that Bioceres Crop Solutions Corp. will post 0.12 EPS for the current fiscal year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.